MALVERN, Pa., July 24, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that three presentations related to plantar fibromatosis (PFI) and plantar fasciitis (PFA) will be shared during ...
DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that data from clinical studies of collagenase clostridium histolyticum (CCH) in patients with plantar ...
Two presentations include data from a Phase 2 study of collagenase clostridium histolyticum (CCH) in patients with plantar fibromatosis Endo is currently enrolling patients in a Phase 3 study A third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results